Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Escherichia coli | 14 | 2026 | 984 | 3.370 |
Why?
|
| DNA, Superhelical | 10 | 2026 | 24 | 2.710 |
Why?
|
| Fluoroquinolones | 8 | 2013 | 93 | 2.100 |
Why?
|
| Drug Resistance, Bacterial | 7 | 2018 | 392 | 1.650 |
Why?
|
| Anti-Bacterial Agents | 11 | 2019 | 2550 | 1.480 |
Why?
|
| DNA | 11 | 2026 | 1413 | 1.470 |
Why?
|
| Klebsiella pneumoniae | 3 | 2016 | 86 | 1.280 |
Why?
|
| DNA Gyrase | 4 | 2026 | 26 | 1.280 |
Why?
|
| Ciprofloxacin | 4 | 2018 | 63 | 0.990 |
Why?
|
| Klebsiella Infections | 2 | 2016 | 61 | 0.940 |
Why?
|
| DNA, Bacterial | 2 | 2026 | 492 | 0.940 |
Why?
|
| Nucleic Acid Conformation | 8 | 2026 | 181 | 0.910 |
Why?
|
| Base Pairing | 1 | 2021 | 40 | 0.700 |
Why?
|
| Endodeoxyribonucleases | 1 | 2021 | 47 | 0.700 |
Why?
|
| Bacterial Proteins | 2 | 2016 | 937 | 0.660 |
Why?
|
| Microbial Sensitivity Tests | 10 | 2019 | 843 | 0.640 |
Why?
|
| DNA Topoisomerases, Type II | 3 | 2026 | 26 | 0.620 |
Why?
|
| DNA Replication | 3 | 2017 | 357 | 0.590 |
Why?
|
| Plasmids | 3 | 2016 | 451 | 0.580 |
Why?
|
| Sugars | 1 | 2019 | 18 | 0.580 |
Why?
|
| Escherichia coli Infections | 3 | 2012 | 194 | 0.570 |
Why?
|
| DNA, Circular | 4 | 2026 | 17 | 0.550 |
Why?
|
| Iron | 2 | 2019 | 305 | 0.550 |
Why?
|
| Escherichia coli Proteins | 3 | 2024 | 310 | 0.540 |
Why?
|
| DNA Ligases | 1 | 2017 | 15 | 0.530 |
Why?
|
| Acinetobacter baumannii | 2 | 2019 | 44 | 0.520 |
Why?
|
| Models, Molecular | 9 | 2026 | 1057 | 0.510 |
Why?
|
| Orthomyxoviridae | 1 | 2016 | 48 | 0.500 |
Why?
|
| beta-Lactam Resistance | 1 | 2016 | 48 | 0.470 |
Why?
|
| beta-Lactamases | 2 | 2016 | 218 | 0.450 |
Why?
|
| Virulence Factors | 1 | 2016 | 180 | 0.440 |
Why?
|
| Bacterial Infections | 1 | 2018 | 324 | 0.440 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2019 | 152 | 0.430 |
Why?
|
| RNA, Viral | 1 | 2016 | 510 | 0.430 |
Why?
|
| Bacteria | 1 | 2018 | 538 | 0.410 |
Why?
|
| Drug Repositioning | 1 | 2013 | 32 | 0.400 |
Why?
|
| Ofloxacin | 3 | 2012 | 29 | 0.380 |
Why?
|
| Levofloxacin | 3 | 2012 | 49 | 0.380 |
Why?
|
| Norfloxacin | 2 | 2008 | 5 | 0.360 |
Why?
|
| Pyridones | 1 | 2013 | 149 | 0.360 |
Why?
|
| Mutation | 6 | 2019 | 6145 | 0.350 |
Why?
|
| Shear Strength | 1 | 2011 | 17 | 0.350 |
Why?
|
| Cryoelectron Microscopy | 4 | 2026 | 241 | 0.340 |
Why?
|
| Genotype | 2 | 2016 | 2611 | 0.340 |
Why?
|
| Gene Transfer Techniques | 2 | 2016 | 342 | 0.330 |
Why?
|
| Respiratory Syncytial Virus, Human | 3 | 2022 | 233 | 0.330 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 2 | 2021 | 80 | 0.320 |
Why?
|
| Base Sequence | 5 | 2026 | 2746 | 0.310 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2010 | 169 | 0.310 |
Why?
|
| Transcriptome | 1 | 2016 | 1130 | 0.300 |
Why?
|
| DNA Topoisomerases | 1 | 2007 | 4 | 0.270 |
Why?
|
| Replicon | 1 | 2007 | 4 | 0.260 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2007 | 20 | 0.260 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2021 | 385 | 0.260 |
Why?
|
| Proteins | 1 | 2012 | 1006 | 0.260 |
Why?
|
| Models, Chemical | 2 | 2021 | 79 | 0.250 |
Why?
|
| Microscopy, Atomic Force | 1 | 2026 | 15 | 0.250 |
Why?
|
| Galactose | 2 | 2019 | 53 | 0.240 |
Why?
|
| DNA Cleavage | 2 | 2026 | 10 | 0.240 |
Why?
|
| Recombination, Genetic | 1 | 2007 | 423 | 0.230 |
Why?
|
| DNA Topoisomerases, Type I | 2 | 2018 | 22 | 0.220 |
Why?
|
| Archaeal Proteins | 2 | 2026 | 7 | 0.200 |
Why?
|
| Hydrodynamics | 1 | 2023 | 28 | 0.200 |
Why?
|
| Stress, Mechanical | 1 | 2021 | 177 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 357 | 0.160 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 73 | 0.160 |
Why?
|
| Genomic Instability | 1 | 2021 | 246 | 0.160 |
Why?
|
| Genetic Vectors | 3 | 2016 | 900 | 0.150 |
Why?
|
| Enterobactin | 1 | 2019 | 2 | 0.150 |
Why?
|
| Klebsiella | 1 | 2019 | 10 | 0.150 |
Why?
|
| Siderophores | 1 | 2019 | 10 | 0.150 |
Why?
|
| Models, Genetic | 1 | 2021 | 747 | 0.140 |
Why?
|
| Genetic Therapy | 3 | 2016 | 718 | 0.140 |
Why?
|
| DNA, Catenated | 1 | 2018 | 3 | 0.140 |
Why?
|
| Sulfolobus solfataricus | 1 | 2018 | 3 | 0.140 |
Why?
|
| Genes, Bacterial | 1 | 2019 | 217 | 0.140 |
Why?
|
| DNA Repair | 1 | 2021 | 580 | 0.140 |
Why?
|
| Enterobacteriaceae | 1 | 2017 | 41 | 0.130 |
Why?
|
| Humans | 16 | 2022 | 130776 | 0.130 |
Why?
|
| Antifungal Agents | 1 | 2019 | 296 | 0.120 |
Why?
|
| Philippines | 1 | 2016 | 22 | 0.120 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2016 | 34 | 0.120 |
Why?
|
| Multilocus Sequence Typing | 1 | 2016 | 63 | 0.120 |
Why?
|
| Carbapenems | 1 | 2016 | 45 | 0.120 |
Why?
|
| Genes | 1 | 2016 | 306 | 0.120 |
Why?
|
| Molecular Epidemiology | 1 | 2016 | 145 | 0.120 |
Why?
|
| Tertiary Care Centers | 1 | 2016 | 249 | 0.110 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2015 | 126 | 0.110 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 142 | 0.110 |
Why?
|
| Gene Fusion | 1 | 2014 | 60 | 0.110 |
Why?
|
| Protein Interaction Maps | 1 | 2014 | 93 | 0.110 |
Why?
|
| DNA Damage | 1 | 2017 | 519 | 0.100 |
Why?
|
| Transfection | 2 | 2016 | 946 | 0.100 |
Why?
|
| Biosynthetic Pathways | 1 | 2013 | 32 | 0.100 |
Why?
|
| Microbial Viability | 1 | 2013 | 43 | 0.100 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 661 | 0.100 |
Why?
|
| Hospitals | 1 | 2016 | 436 | 0.100 |
Why?
|
| Drug Resistance, Microbial | 1 | 2013 | 198 | 0.100 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 117 | 0.100 |
Why?
|
| DNA Topoisomerase IV | 2 | 2012 | 10 | 0.100 |
Why?
|
| Cells | 1 | 2012 | 20 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2017 | 803 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 303 | 0.090 |
Why?
|
| Gene Expression | 1 | 2016 | 1489 | 0.090 |
Why?
|
| Sonication | 1 | 2011 | 7 | 0.090 |
Why?
|
| Aerosols | 1 | 2011 | 58 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 6784 | 0.090 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2011 | 60 | 0.090 |
Why?
|
| Antibodies, Viral | 3 | 2022 | 1166 | 0.080 |
Why?
|
| Viral Fusion Proteins | 2 | 2021 | 74 | 0.080 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2010 | 50 | 0.080 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2010 | 117 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2010 | 183 | 0.080 |
Why?
|
| Membrane Transport Proteins | 1 | 2010 | 181 | 0.080 |
Why?
|
| Prevalence | 1 | 2016 | 2684 | 0.070 |
Why?
|
| Sentinel Surveillance | 1 | 2008 | 26 | 0.070 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2007 | 12 | 0.070 |
Why?
|
| Hospitals, County | 1 | 2008 | 22 | 0.070 |
Why?
|
| Kinetics | 2 | 2021 | 1087 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 2 | 2021 | 519 | 0.070 |
Why?
|
| United States | 2 | 2016 | 11834 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2007 | 340 | 0.060 |
Why?
|
| Texas | 2 | 2021 | 3634 | 0.060 |
Why?
|
| Protein Binding | 2 | 2026 | 1660 | 0.060 |
Why?
|
| Computer Simulation | 3 | 2017 | 680 | 0.060 |
Why?
|
| Peptides | 2 | 2021 | 710 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2849 | 0.050 |
Why?
|
| Aged | 2 | 2016 | 20958 | 0.050 |
Why?
|
| Static Electricity | 2 | 2017 | 44 | 0.050 |
Why?
|
| Sex Factors | 1 | 2008 | 1341 | 0.050 |
Why?
|
| Ultracentrifugation | 1 | 2023 | 20 | 0.050 |
Why?
|
| Phenotype | 1 | 2013 | 4479 | 0.050 |
Why?
|
| Protein Domains | 1 | 2024 | 251 | 0.050 |
Why?
|
| Adult | 4 | 2022 | 31269 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 2341 | 0.050 |
Why?
|
| Male | 3 | 2016 | 64680 | 0.050 |
Why?
|
| Young Adult | 1 | 2016 | 10021 | 0.040 |
Why?
|
| Female | 3 | 2016 | 70630 | 0.040 |
Why?
|
| Age Factors | 1 | 2008 | 2849 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2021 | 227 | 0.040 |
Why?
|
| Seasons | 1 | 2022 | 335 | 0.040 |
Why?
|
| Mice | 1 | 2016 | 18208 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2021 | 15011 | 0.040 |
Why?
|
| Animals | 2 | 2017 | 33891 | 0.040 |
Why?
|
| DNA, Archaeal | 1 | 2018 | 4 | 0.030 |
Why?
|
| DNA, Concatenated | 1 | 2018 | 5 | 0.030 |
Why?
|
| Torsion, Mechanical | 1 | 2017 | 6 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 2017 | 39 | 0.030 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 71 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2018 | 141 | 0.030 |
Why?
|
| Electroporation | 1 | 2016 | 36 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2937 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 3700 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 366 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 378 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2016 | 688 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2008 | 8567 | 0.030 |
Why?
|
| Fluorescence | 1 | 2014 | 93 | 0.030 |
Why?
|
| Child | 2 | 2021 | 26214 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2014 | 156 | 0.030 |
Why?
|
| Infant | 1 | 2008 | 13323 | 0.020 |
Why?
|
| Quinolones | 1 | 2012 | 55 | 0.020 |
Why?
|
| Culture Media | 1 | 2012 | 172 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 321 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 297 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6494 | 0.020 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2009 | 16 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 528 | 0.020 |
Why?
|
| Adolescent | 1 | 2008 | 20832 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 766 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 586 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2009 | 257 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 1457 | 0.020 |
Why?
|
| Middle Aged | 1 | 2008 | 28499 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 1144 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2010 | 2474 | 0.010 |
Why?
|